Title |
F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis
|
---|---|
Published in |
AMB Express, February 2021
|
DOI | 10.1186/s13568-021-01197-6 |
Pubmed ID | |
Authors |
Youlian Zhou, Haoming Xu, Jing Xu, Xue Guo, Hailan Zhao, Ye Chen, Yongjian Zhou, Yuqiang Nie |
Abstract |
An increasing number of studies have shown that Faecalibacterium prausnitzii (F. prausnitzii) is a promising anti-inflammatory bacterium that colonizes in the gut and that gut microbiota dysbiosis plays an important role in the pathogenesis of inflammatory bowel disease (IBD). In this study, we report the gut microbiota profile of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis mice treated with F. prausnitzii and its supernatant on the basis of high-throughput sequencing. We interestingly found that both F. prausnitzii and its metabolites exerted protective effects against colitis in mice, which ameliorated gut dysbiosis, with an increase in bacterial diversity and the abundance of short-chain fatty acid (SCFA)-producing bacteria and a decrease in serum TNF-α and the abundance of Proteinbacteria, Acidobacteria, and Bacteroidetes. These findings will provide further evidence of the anti-inflammatory effect of F. prausnitzii, which presents therapeutic potential for IBD treatment. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 3 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 38 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 9 | 24% |
Researcher | 6 | 16% |
Student > Bachelor | 2 | 5% |
Lecturer | 2 | 5% |
Student > Master | 1 | 3% |
Other | 1 | 3% |
Unknown | 17 | 45% |
Readers by discipline | Count | As % |
---|---|---|
Immunology and Microbiology | 6 | 16% |
Agricultural and Biological Sciences | 5 | 13% |
Medicine and Dentistry | 4 | 11% |
Biochemistry, Genetics and Molecular Biology | 2 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Other | 2 | 5% |
Unknown | 18 | 47% |